AI assistant
Sending…
Britannia Life Sciences — AGM Information 2026
Jan 12, 2026
45110_rns_2026-01-12_b32f18b8-6706-4223-a70c-1be87b3ad4cb.pdf
AGM Information
Open in viewerOpens in your device viewer
January 12, 2026
ODYSSEY
Filed via SEDAR+
To All Applicable Exchanges and Securities Administrators
Subject: Britannia Life Sciences Inc. (the "Issuer") Notice of Meeting and Record Date
Dear Sir/Madam:
We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:
| Meeting Type: | Annual General Meeting |
|---|---|
| Meeting Date: | February 24, 2026 |
| Record Date for Notice of Meeting: | January 16, 2026 |
| Record Date for Voting (if applicable): | January 16, 2026 |
| Beneficial Ownership Determination Date: | January 16, 2026 |
| Class of Securities Entitled to Vote: | COMMON SHARES |
| ISIN: | CA11042D1087 |
| Issuer sending proxy materials directly to NOBOs: | No |
| Issuer paying for delivery to OBOs: | No |
| Notice and Access for Beneficial Holders: | No |
| Notice and Access for Registered Holders: | No |
In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.
Yours truly,
Odyssey Trust Company
as agent for Britannia Life Sciences Inc.
More from Britannia Life Sciences
Transaction in Own Shares
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Mar 2
Proxy Solicitation & Information Statement
2026
Feb 3
Proxy Solicitation & Information Statement
2026
Feb 3
Proxy Solicitation & Information Statement
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2025
Dec 1